Cited 0 times in Scipus Cited Count

Early Prophylactic Use of Curosurf® Versus Newfactan® for Respiratory Distress Syndrome in Premature Infants

Na, YJ | Lee, JH  | Park, MS
Perinatology, 27(3). : 162-167, 2016
Journal Title
Purpose: This study was done to compare the prophylactic efficacy of surfactant with Curosurf® and Newfactan®.
Methods: Preterm infants treated with pulmonary surfactant within 30 minutes after birth from January 2008 to December 2014 were included in this study. The subjects were divided into a group that received Curosurf® (n=163) and a group that received Newfactan® (n=120). The data were collected retrospectively using the patients' medical records.
Results: Demographic factors did not differ between the groups. The incidence rates of surfactant re-dosing, pulmonary air leaks, postnatal steroid therapy use, pulmonary hemorrhage, moderate to severe bronchopulmonary dysplasia, and duration of mechanical ventilation, were not different between the groups. The sequential changes of ventilator parameters after surfactant instillation were not different between the groups. No differences in the incidence rates of patent ductus arteriosus, intraventricular hemorrhage (≥grade III), periventricular leukomalacia, retinopathy of prematurity, necrotizing enterocolitis (≥stage IIa), mortality, sepsis, or duration of hospital stay were observed between the groups.
Conclusion: The results indicate no differences in the clinical efficacy of early prophylactic use of Curosurf® versus Newfactan®.

Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pediatrics & Adolescent Medicine
Ajou Authors
박, 문성  |  이, 장훈
Files in This Item:
There are no files associated with this item.


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.